...
首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells.
【24h】

Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells.

机译:从人类ES和iPS细胞定向分化造血前体和功能破骨细胞。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The directed differentiation of human pluripotent stem cells offers the unique opportunity to generate a broad spectrum of human cell types and tissues for transplantation, drug discovery, and studying disease mechanisms. Here, we report the stepwise generation of bone-resorbing osteoclasts from human embryonic and induced pluripotent stem cells. Generation of a primitive streak-like population in embryoid bodies, followed by specification to hematopoiesis and myelopoiesis by vascular endothelial growth factor and hematopoietic cytokines in serum-free media, yielded a precursor population enriched for cells expressing the monocyte-macrophage lineage markers CD14, CD18, CD11b, and CD115. When plated in monolayer culture in the presence of macrophage colony-stimulating factor and receptor activator of nuclear factor-kappaB ligand (RANKL), these precursors formed large, multinucleated osteoclasts that expressed tartrate-resistant acid phosphatase and were capable of resorption. No tartrate-resistant acid phosphatase-positive multinucleated cells or resorption pits were observed in the absence of RANKL. Molecular analyses confirmed the expression of the osteoclast marker genes NFATc1, cathepsin K, and calcitonin receptor in a RANKL-dependent manner, and confocal microscopy demonstrated the coexpression of the alphavbeta3 integrin, cathepsin K and F-actin rings characteristic of active osteoclasts. Generating hematopoietic and osteoclast populations from human embryonic and induced pluripotent stem cells will be invaluable for understanding embryonic bone development and postnatal bone disease.
机译:人类多能干细胞的定向分化提供了独特的机会,可以产生广泛的人类细胞类型和组织,用于移植,药物发现和研究疾病机制。在这里,我们报告从人类胚胎和诱导多能干细胞逐步产生的骨吸收破骨细胞。在无血清培养基中生成原始条状样种群,然后通过血管内皮生长因子和造血细胞因子在无血清培养基中确定造血和骨髓生成,从而产生了富集表达单核巨噬细胞谱系标记CD14,CD18的细胞的前体种群。 ,CD11b和CD115。当在巨噬细胞集落刺激因子和核因子-κB配体(RANKL)受体活化剂存在下单层培养时,这些前体形成大型的多核破骨细胞,表达抗酒石酸酸性磷酸酶并能够吸收。在没有RANKL的情况下,未观察到抗酒石酸的酸性磷酸酶阳性的多核细胞或吸收坑。分子分析证实了破骨细胞标记基因NFATc1,组织蛋白酶K和降钙素受体的表达以RANKL依赖性方式表达,共聚焦显微镜证实了活性破骨细胞特有的alphavbeta3整合素,组织蛋白酶K和F-肌动蛋白环的共表达。从人类胚胎干细胞和诱导多能干细胞中生成造血和破骨细胞群体对于了解胚胎骨发育和产后骨骼疾病将具有不可估量的价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号